Cargando…
Role of vasopressin and terlipressin in refractory shock compared to conventional therapy in the neonatal and pediatric population: a systematic review, meta-analysis, and trial sequential analysis
BACKGROUND: Vasopressin (AVP) and terlipressin (TP) have been used as last-line therapy in refractory shock in children. However, the efficacy and safety profiles of AVP and TP have not been determined in pediatric refractory shock of different origins. We aimed to assess the efficacy and safety of...
Autores principales: | Masarwa, Reem, Paret, Gideon, Perlman, Amichai, Reif, Shimon, Raccah, Bruria Hirsh, Matok, Ilan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217634/ https://www.ncbi.nlm.nih.gov/pubmed/28057037 http://dx.doi.org/10.1186/s13054-016-1589-6 |
Ejemplares similares
-
Vasopressin vs Terlipressin in Treatment of Refractory Shock
por: Scarpati, G, et al.
Publicado: (2013) -
Effect of Enzyme-Inducing Antiseizure Medications on the Risk of Sub-Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study
por: Perlman, Amichai, et al.
Publicado: (2021) -
Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis
por: Rotshild, Victoria, et al.
Publicado: (2021) -
Calcium Channel Blocker Use and the Risk for Breast Cancer: A Population-Based Nested Case-Control Study
por: Rotshild, Victoria, et al.
Publicado: (2022) -
Anti-Remodeling Cardiac Therapy in Patients With Duchenne Muscular Dystrophy, Meta-Analysis Study
por: Raccah, Bruria Hirsh, et al.
Publicado: (2022)